NYSE · PHARMACEUTICAL PREPARATIONS · SMALL CAP
Nuvation Bio Inc. NUVB
6 fiscal years on record · USD · FY2025 reported · SEC filings only
$-204.6M
Growth
USD 62.9M
Revenue, FY2025 · full 6-year series below
Revenue $M
Net income $M
FY2025 · Revenue 62.9 · Net income -204.6
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−325 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -338.7% · Net -325.3%
ROE
FY2025 · ROE -53.2%
Each USD of equity lost 53 cents this year.
The 6-year record
6 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue $B | 0.1 | 0.0 | 0.0 | · | · | · |
| Operating income $B | −0.2 | −0.6 | −0.1 | −0.1 | −0.1 | −0.0 |
| EBITDA $B | · | · | · | · | · | · |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.2 | −0.6 | −0.1 | −0.1 | −0.1 | −0.0 |
| EPS, diluted $ | −0.60 | −2.11 | −0.35 | −0.48 | −0.44 | −0.43 |
| Dividend / sh $ | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · |
| ROE % | −53.2 | −106.3 | −12.0 | −14.9 | −18.1 | −19.4 |
| Shares out B | 0.34 | 0.34 | 0.22 | 0.22 | 0.22 | 0.15 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 26 reconciliationsAUDITED
Reconciled in 6 of 19 fiscal years. 69 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPharmaceutical Preparations
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2020